ICD-10-CM Billable Code

C82.17

Follicular lymphoma grade II, spleen

Clinical Classification Guidelines

Medical Intelligence & Overview

Follicular lymphoma is a type of non-Hodgkin lymphoma that originates in the lymphatic system, particularly affecting lymph nodes and splenic tissue. When classified as grade II, it refers to a specific level of how the cancer cells look under a microscope, indicating a moderate level of cell division. This report focuses on follicular lymphoma involving the spleen (ICD-10 code C82.17), which can affect the spleen's function and overall health. Awareness and understanding of this condition are essential for patients and caregivers to navigate diagnosis, treatment options, and disease management.

Causes & Symptoms

Clinical Causes: Genetic mutations in lymphoid cells Increased exposure to certain chemicals or toxins Aging-related changes in immune system cells Family history of lymphoma or other lymphatic cancers Immune system suppression due to medications or medical conditions

Key Symptoms: Swelling or painless enlargement of the spleen (splenomegaly) General fatigue or weakness Unexplained weight loss Fever that persists without infection Night sweats Frequent infections or increased susceptibility Abdominal pain or fullness on the left side

Diagnostic & Treatment

Diagnosis Path: Diagnosis typically involves a combination of medical history review, physical examination, and diagnostic tests. Key steps include:

Treatment Protocols: Treatment options depend on various factors such as disease stage, overall health, and specific patient needs. Common approaches include:

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is C82.17 a billable ICD-10 code?
Yes, C82.17 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report C82.17?
Clinical documentation must specify the nature of Follicular lymphoma grade II, spleen and any associated comorbidities for accurate reporting.

Cite this Clinical Reference